Cargando…
TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines
Governed through the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) since 1995, the current medical R&D system requires significant trade-offs between innovation and high monopoly prices for patented drugs that restrict patient access to medic...
Autores principales: | Mermelstein, Shiri, Stevens, Hilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779122/ https://www.ncbi.nlm.nih.gov/pubmed/35056944 http://dx.doi.org/10.3390/pharmaceutics14010048 |
Ejemplares similares
-
Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence
por: Urias, Eduardo, et al.
Publicado: (2020) -
Open source licensing: software freedom and intellectual property law
por: Rosen, Lawrence E
Publicado: (2005) -
The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement
por: Motari, Marion, et al.
Publicado: (2021) -
A License to Practice Medicine Cannot Be a License to Harm
por: Schluger, Neil W., et al.
Publicado: (2022) -
Accelerating pooled licensing of medicines to enhance global production and equitable access
por: Shadlen, Kenneth C
Publicado: (2022)